Saltar al contenido
Merck

Delirious mania: detection, diagnosis, and clinical management in the acute setting.

Journal of psychiatric practice (2013-01-22)
Natalie L Jacobowski, Stephan Heckers, William V Bobo
RESUMEN

Delirious mania is a severe but under-recognized neuropsychiatric syndrome characterized by the rapid onset of delirium, mania, and psychosis, not associated with a prior toxicity, physical illness, or mental disorder. Catatonia is often a prominent feature of the syndrome. While initially believed to be rare, recent reports suggest that delirious mania may constitute up to 15% of all acute mania cases. When delirious mania is unrecognized or improperly treated, it can progress rapidly in severity and can become life-threatening. This article reviews the pathophysiology, diagnosis, and treatment of delirious mania and includes a detailed case report. Delirious mania is robustly responsive to high-dose lorazepam or electroconvulsive therapy (ECT); thus, early recognition and definitive treatment can be life-saving.

MATERIALES
Número de producto
Marca
Descripción del producto

Supelco
Lorazepam solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Sigma-Aldrich
(±)-Lorazepam
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Lorazepam for system suitability, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Lorazepam, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad